Response to: 'MBDA: what is it good for?' by Yazici et al
Ann Rheum Dis
.
2014 Nov;73(11):e73.
doi: 10.1136/annrheumdis-2014-206383.
Epub 2014 Aug 28.
Authors
Ronald van Vollenhoven
1
,
Karen Hambardzumyan
1
,
David Chernoff
2
,
Rebecca Bolce
2
Affiliations
1
Department of Medicine, The Karolinska Institute, Stockholm, Sweden.
2
Department of Medicine, Crescendo Bioscience Inc., South San Francisco, California, USA.
PMID:
25169731
DOI:
10.1136/annrheumdis-2014-206383
No abstract available
Keywords:
Adult Onset Still's Disease; Amyloidosis; Analgesics.
Publication types
Letter
Comment
MeSH terms
Arthritis, Rheumatoid / diagnosis*
Biomarkers / blood*
Humans
Substances
Biomarkers